What is a stock summary page? Click here for an overview.
Business Description
Immuron Ltd
Share Class Description:
IMRNW: Warrants (12/05/2022)Description
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 44.46 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -3.95 | |||||
| Beneish M-Score | -0.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 180.2 | |||||
| 3-Year EBITDA Growth Rate | 7.6 | |||||
| 3-Year EPS without NRI Growth Rate | 8 | |||||
| 3-Year FCF Growth Rate | -13 | |||||
| 3-Year Book Growth Rate | -21.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.8 | |||||
| Quick Ratio | 5.92 | |||||
| Cash Ratio | 4.47 | |||||
| Days Inventory | 269.98 | |||||
| Days Sales Outstanding | 38.6 | |||||
| Days Payable | 205.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 0.09 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.47 | |||||
| Operating Margin % | -100.28 | |||||
| Net Margin % | -112.41 | |||||
| ROE % | -54.36 | |||||
| ROA % | -46.34 | |||||
| ROIC % | -293.6 | |||||
| 3-Year ROIIC % | 2944.09 | |||||
| ROC (Joel Greenblatt) % | -1263.47 | |||||
| ROCE % | -53.81 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.5 | |||||
| PB Ratio | 1.56 | |||||
| EV-to-EBIT | -0.62 | |||||
| EV-to-EBITDA | -0.62 | |||||
| EV-to-Revenue | 0.7 | |||||
| EV-to-FCF | -0.58 | |||||
| Earnings Yield (Greenblatt) % | -161.29 | |||||
| FCF Yield % | -49.06 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:IMRNW
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Immuron Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0 - 1.2 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Immuron Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Immuron Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Immuron Ltd Frequently Asked Questions
What is Immuron Ltd(IMRNW)'s stock price today?
The current price of IMRNW is $0.07. The 52 week high of IMRNW is $1.20 and 52 week low is $0.00.
When is next earnings date of Immuron Ltd(IMRNW)?
The next earnings date of Immuron Ltd(IMRNW) is .
Does Immuron Ltd(IMRNW) pay dividends? If so, how much?
Immuron Ltd(IMRNW) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers